|Bid||151.51 x 900|
|Ask||155.79 x 1000|
|Day's Range||152.29 - 156.90|
|52 Week Range||141.95 - 226.61|
|Beta (3Y Monthly)||1.02|
|PE Ratio (TTM)||13.23|
|Forward Dividend & Yield||0.04 (0.03%)|
|1y Target Est||N/A|
The Healthcare Transformation Alliance, led by former N.J. Congressman Rob Andrews, has saved its members at least $400 million in overall health care spending.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
The right mergers and acquisitions (M&A;) can make a good company even better by opening up new markets, expanding capabilities and market share, and diversifying product lines.Not every deal is a guaranteed winner, but investors typically benefit from smart M&A.; A 2016 Booth Business School study found, on average, an increase in overall value for both the acquiring and acquired companies at the time of the merger, and a long-term rise in value for companies that made cash acquisitions.Consider the $81 billion merger between Exxon and Mobil in 1999 that created Exxon Mobil (XOM) - now a $300 billion goliath and the largest publicly traded energy company on U.S. exchanges. Or there's Walt Disney's (DIS) $6 billion buyout of Pixar in 2006. The studio's animated films have generated nearly $11 billion in worldwide box office alone, not accounting for merchandise and other related opportunities.Last year was an especially good year for corporate M&A; thanks to major catalysts provided by tax reform, low borrowing costs and a healthy stock market. Dealmaking hit near-record levels last year. According to Mergermarket, 5,718 transactions closed, and deal volume exceeded $1.5 trillion - the second-highest total ever. Also noteworthy was last year's surge in "mega-deals" - transactions valued at more than $10 billion. These included Keurig Dr. Pepper's (KDP) $27 billion acquisition of soft drink maker Dr. Pepper Snapple Group and pharmacy chain CVS Health's (CVS) $70 billion takeover of health insurance provider Aetna.Here are 15 large-cap stocks that are looking for big things out of their pending or recently closed M&A; deals. These mergers and acquisitions are either already sparking new life in the acquiring companies, or analysts and other market professionals expect them to do so over the coming years. SEE ALSO: The Berkshire Hathaway Portfolio: All 47 Buffett Stocks Explained
Investing.com – Investors are betting big on Boeing (NYSE:BA) for now, and the Dow Jones Industrial Average was the beneficiary on Thursday.
Oscar Insurance Corp. expansion comes as other health insurers are expanding their Affordable Care Act plan offerings for next year.
In what will likely be a good test of a market in which there has been few major office sales of late, 2000 Park Lane is up for sale. Sources familiar with the marketing of the property indicate the Parkway West complex is being shopped around by its owner, Atlanta Property Group, which bought it in a seven-building portfolio deal a little more than two years ago. The Pittsburgh property, totaling nearly 235,000 square feet and located in North Fayette, was the first buy of its kind by the company and is the only one listed outside its southern territory that extends from North Carolina through central Georgia and into Florida.
Cigna's move to shed it underscores its decision to focus on healthcare following its $54-billion acquisition of pharmacy benefits manager Express Scripts Holding Co last year. The Bloomfield, Connecticut-based company is working with an investment bank to run an auction for the group benefits business, the sources said.
Cigna (CI) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Cigna Corporation and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers. This publication does not announce a credit rating action and is not an indication of whether or not a credit rating action is likely in the near future.
Radian Group's (RDN) new share repurchase program reflects effective capital deployment backed by solid financial position banking on strong core operations.
Assurant (AIZ) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Gilead Sciences Inc hopes to soon introduce a pricey new pill to prevent HIV in people at risk of contracting the infection, but the drugmaker faces opposition from an unusual source: patient advocates. Such groups have traditionally lobbied for insurance coverage of newer HIV drugs regardless of expense. A generic version of the current prevention pill, Truvada, is due in the United States in September 2020, which should bring down costs and give many more people access to the therapy, they say.
Shares of health insurance giant Cigna Corp. rose after Alliance Bernstein upgraded the stock’s rating, citing future earnings growth and a stock valuation that is too low.
Yahoo Finance's Anjalee Khemlani weighs on how Amazon and Pill Pack are facing resistance from pharmacies on YFi AM. She says, "right now, CVS and Walgreens are claiming that Pill Pack improperly obtained information of their customers … but there is no real hard evidence."